Promoter methylation of cyclin A1 is associated with human papillomavirus 16 induced head and neck squamous cell carcinoma independently of p53 mutation

Cervical dysplasia: Assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy

(2010) Elaine H. Lim et al.   GYNECOLOGIC ONCOLOGY

HPV-associated head and neck cancer: a virus-related cancer epidemic

(2010) Shanthi Marur et al.   LANCET ONCOLOGY

Mutant p53 and cyclin A1 protein expression in primary laryngeal squamous cell carcinomas do not correlate to second primary tumours of the head and neck*

(2009) Ross D. Farhadieh et al.   ANZ JOURNAL OF SURGERY

Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation

(2009) Emanuela Taioli et al.   BMC CANCER

Human Papillomavirus and Oropharyngeal Cancer: What You Need to Know in 2009

(2009) M. Boyd Gillespie et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Evaluation of Promoter Hypermethylation Detection in Body Fluids as a Screening/Diagnosis Tool for Head and Neck Squamous Cell Carcinoma

(2008) A. L. Carvalho et al.   CLINICAL CANCER RESEARCH